243 related articles for article (PubMed ID: 29924937)
1. Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing.
Qu J; Zhu L; Zhou Z; Chen P; Liu S; Locy ML; Thannickal VJ; Zhou Y
Am J Respir Crit Care Med; 2018 Sep; 198(5):599-609. PubMed ID: 29924937
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells.
Hao Y; Bates S; Mou H; Yun JH; Pham B; Liu J; Qiu W; Guo F; Morrow JD; Hersh CP; Benway CJ; Gong L; Zhang Y; Rosas IO; Cho MH; Park JA; Castaldi PJ; Du F; Zhou X
Am J Respir Crit Care Med; 2020 Nov; 202(9):1225-1236. PubMed ID: 32551799
[No Abstract] [Full Text] [Related]
3. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
[TBL] [Abstract][Full Text] [Related]
5. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.
Hanzawa N; Hashimoto K; Yuan X; Kawahori K; Tsujimoto K; Hamaguchi M; Tanaka T; Nagaoka Y; Nishina H; Morita S; Hatada I; Yamada T; Ogawa Y
Sci Rep; 2020 Mar; 10(1):5181. PubMed ID: 32198422
[TBL] [Abstract][Full Text] [Related]
6. Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis.
Mathai SK; Pedersen BS; Smith K; Russell P; Schwarz MI; Brown KK; Steele MP; Loyd JE; Crapo JD; Silverman EK; Nickerson D; Fingerlin TE; Yang IV; Schwartz DA
Am J Respir Crit Care Med; 2016 May; 193(10):1151-60. PubMed ID: 26669357
[TBL] [Abstract][Full Text] [Related]
7. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.
Sapozhnikov DM; Szyf M
Nat Protoc; 2022 Dec; 17(12):2840-2881. PubMed ID: 36207463
[TBL] [Abstract][Full Text] [Related]
9. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-based epigenome editing: mechanisms and applications.
Fadul SM; Arshad A; Mehmood R
Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
Goubert D; Koncz M; Kiss A; Rots MG
Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
[TBL] [Abstract][Full Text] [Related]
12. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
[TBL] [Abstract][Full Text] [Related]
13. dCas9: A Versatile Tool for Epigenome Editing.
Brocken DJW; Tark-Dame M; Dame RT
Curr Issues Mol Biol; 2018; 26():15-32. PubMed ID: 28879853
[TBL] [Abstract][Full Text] [Related]
14. Advances of epigenetic editing.
Gjaltema RAF; Rots MG
Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
[TBL] [Abstract][Full Text] [Related]
15. Editing DNA Methylation in the Mammalian Genome.
Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
[TBL] [Abstract][Full Text] [Related]
16. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells.
Marx N; Grünwald-Gruber C; Bydlinski N; Dhiman H; Ngoc Nguyen L; Klanert G; Borth N
Biotechnol J; 2018 Oct; 13(10):e1700217. PubMed ID: 29802757
[TBL] [Abstract][Full Text] [Related]
18. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
19. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
Lau CH; Suh Y
Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]